glp-1 blockers in fast food Slideshow: friendly innovations on the upswing Smaller portions, more protein: How

Most are administered via subcutaneous injection, with Rybelsus (oral semaglutide) being the exception

As GLP-1 medications normalize smaller appetites and higher protein intake, national restaurant chains are quietly redesigning their menus offering customers scaled-down portions at lower prices, whether theyre on the drugs or not

And its not the first time the industry has weathered a weight loss trend

The mechanism of action involves several physiological pathways

And these companies are well aware of these risks and will be able to adapt if necessary. That could be through reducing portion sizes, or using healthier ingredients